Document ID: chunk:federal_register_of_legislation:F2023L00175:reg:9:p4
Version: federal_register_of_legislation:F2023L00175
Segment Type: reg
Provision Reference: reg 9 (pt 4/4)
Character Range: 13099–15027

worsening of chronic obstructive pulmonary disease; and
(b)          if that exposure has ceased, the clinical worsening of chronic obstructive pulmonary disease has occurred within 20 years of cessation;
Note: dust is defined in the Schedule 1 – Dictionary.
(23)      inhaling ambient polluted air as specified:
(a)          for a cumulative period of at least 70,000 hours before the clinical worsening of chronic obstructive pulmonary disease; and
(b)          if that exposure has ceased, the clinical worsening of chronic obstructive pulmonary disease has occurred within 20 years of cessation;
Note: ambient polluted air as specified is defined in the Schedule 1 – Dictionary.
(24)      having infection with human immunodeficiency virus before the clinical worsening of chronic obstructive pulmonary disease;
(25)      having at least 2 episodes of acute viral or bacterial lower respiratory tract infection requiring medical treatment within the 1 year before the clinical worsening of chronic obstructive pulmonary disease;
Note: lower respiratory tract is defined in the Schedule 1 – Dictionary.
(26)      having pulmonary tuberculosis at least 1 year before the clinical worsening of chronic obstructive pulmonary disease;
Note: pulmonary tuberculosis is defined in the Schedule 1 – Dictionary.
(27)      having alpha-1 antitrypsin deficiency at the time of the clinical worsening of chronic obstructive pulmonary disease;
(28)      having asthma before the clinical worsening of chronic obstructive pulmonary disease;
(29)      having bronchiectasis before the clinical worsening of chronic obstructive pulmonary disease;
(30)      having gastro-oesophageal reflux disease, with erosive oesophagitis or oesophageal stricture within 2 years before the clinical worsening of chronic obstructive pulmonary disease;
(31)      inability to obtain appropriate clinical management for chronic obstructive pulmonary disease.